Determination of Skeletal Tumor Burden on 18F-Fluoride PET/CT

被引:54
|
作者
Rohren, Eric M. [1 ]
Etchebehere, Elba C. [1 ,2 ]
Araujo, John C. [3 ]
Hobbs, Brian P. [4 ]
Swanston, Nancy M. [1 ]
Everding, Michael [1 ]
Moody, Tracy [1 ]
Macapinlac, Homer A. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Nucl Med, Houston, TX 77030 USA
[2] Univ Estadual Campinas, UNICAMP, Div Nucl Med, Campinas, SP, Brazil
[3] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
关键词
fluoride PET/CT; NaF PET/CT; prostate cancer; bone metastases; skeletal tumor burden; POSITRON-EMISSION-TOMOGRAPHY; PLANAR BONE-SCINTIGRAPHY; TOTAL LESION GLYCOLYSIS; PROSTATE-CANCER; F-18-FDG PET/CT; PROGNOSTIC VALUE; F-18-SODIUM FLUORIDE; RESPONSE ASSESSMENT; HODGKINS-LYMPHOMA; CELL;
D O I
10.2967/jnumed.115.156026
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The purpose of this study was to define a method to assess skeletal tumor burden with F-18-labeled sodium fluoride PET/CT (F-18-fluoride PET/CT) and evaluate the reproducibility of these measurements. Methods: Ninety-eight consecutive patients (90 men; mean age +/- SD, 65.7 +/- 14.2 y) underwent 158 F-18-fluoride PET/CT scans for evaluation of skeletal metastatic disease. In order to determine the mean normal bone SUV, initially a 1-cm spheric volume of interest (V01) was placed over 5 bone sites: T12, L5, sacrum, right iliac bone, and right femur. For each patient, the mean SUVmax, for all sites was generated. Afterward, a threshold value of normal bone uptake was established. Subsequently, skeletal tumor burden was determined by generating volumetric data using a whole-body segmentation method. Any SUVmax below the normal threshold was excluded from analysis, as were VOls not related to metastatic disease. Statistics for the remaining VOls were then generated and defined as the skeletal metastatic tumor burden by 2 parameters: total lesion fluoride uptake above an SUVmax of 10 (TLF10) and fluoride tumor volume above an SUVmax of 10 (FTV10). TLF10 and FIV10 reproducibility was determined using 2 independent and experienced PET/CT interpreters analyzing a subset of 13 F-18-fluoride PET/CT scans. Results: Mean (+/- SD) normal. bone SUVmax was 6.62 +/- 1.55 for T12, 6.11 +/- 1.73 for L5, 4.59 +/- 1.74 for sacrum, 5.39 +/- 1.72 for right iliac bone, and 3.90 +/- 1.57 for right femur. The mean normal SUVmax for all 543 sites was 5.32 +/- 0.99. On the basis of these values, an SUVmax threshold of 10 was chosen to exclude normal bone from the volumetric calculations. Semiautomated measurements of TLF10 and FTV10 exhibited high interobserver reproducibility, within +/- 0.77% and +/- 3.62% of the interinterpreter average for TLF10 and FTV10, respectively. Conclusion: Determination of skeletal tumor burden with F-18-fluoride PET/CT is feasible and highly reproducible. Using an SUVmax threshold of 10 excludes nearly all normal bone activity from volumetric calculations.
引用
收藏
页码:1507 / 1512
页数:6
相关论文
共 50 条
  • [21] Usefulness of 18F-Fluoride PET/CT in Bone Metastasis of Prostate Cancer
    Park, M.
    Kim, J.
    Park, H.
    Kang, C.
    Lim, H.
    Kim, J.
    Lee, C.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S481 - S481
  • [22] 18F-fluoride PET/CT for bone scanning Role of attenuation correction
    Nagarajah, J.
    Dannat, T.
    Hartung, V.
    Bockisch, A.
    Rosenbaum-Krumme, S.
    [J]. NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2012, 51 (03): : 84 - 87
  • [23] 18F-FLUORIDE PET/CT FOR DETECTION OF AXIAL INVOLVEMENT IN ANKYLOSING SPONDYLITIS
    Idolazzi, L.
    Vantaggiato, E.
    Salgarello, M.
    Perandini, S.
    Fassio, A.
    Povino, M. R.
    Fracassi, E.
    Viaplana, O.
    Gatti, D.
    Rossini, M.
    Adami, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1158 - 1158
  • [24] Sodium 18F-Fluoride PET/CT of Bone, Joint, and Other Disorders
    Jadvar, Hossein
    Desai, Bhushan
    Conti, Peter S.
    [J]. SEMINARS IN NUCLEAR MEDICINE, 2015, 45 (01) : 58 - 65
  • [25] Airway Involvement of Relapsing Polychondritis Revealed by 18F-Fluoride PET/CT
    Zhang, Wei
    Zhu, Zhaohui
    [J]. CLINICAL NUCLEAR MEDICINE, 2015, 40 (04) : 352 - 354
  • [26] Assessment of atherosclerosis in oncologic patients using 18F-fluoride PET/CT
    Seiji Kurata
    Ukihide Tateishi
    Kazuya Shizukuishi
    Tomohiro Yoneyama
    Ayako Hino
    Hayato Kaida
    Kiminori Fujimoto
    Masatoshi Ishibashi
    Tomio Inoue
    [J]. Annals of Nuclear Medicine, 2013, 27 : 481 - 486
  • [27] Comparison of 18F-fluoride PET/MR and PET/CT in Patients with Chronic Foot Pain
    Rauscher, I.
    Beer, A. J.
    Souvatzoglou, M.
    Schwaiger, M.
    Eiber, M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S407 - S407
  • [28] Precision of 18F-fluoride PET skeletal kinetic studies in the assessment of bone metabolism
    Y. Al-beyatti
    M. Siddique
    M. L. Frost
    I. Fogelman
    G. M. Blake
    [J]. Osteoporosis International, 2012, 23 : 2535 - 2541
  • [29] Precision of 18F-fluoride PET skeletal kinetic studies in the assessment of bone metabolism
    Al-beyatti, Y.
    Siddique, M.
    Frost, M. L.
    Fogelman, I.
    Blake, G. M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2012, 23 (10) : 2535 - 2541
  • [30] Clinical usefulness of 18F-fluoride bone PET
    Kang J.Y.
    Lee W.W.
    So Y.
    Lee B.C.
    Kim S.E.
    [J]. Nuclear Medicine and Molecular Imaging, 2010, 44 (1) : 55 - 61